ProShare Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $28.4M | Sell |
57,741
-13,559
| -19% | -$7.36M | 0.04% | 207 |
|
|
2025
Q4 | $41.3M | Buy |
71,300
+5,554
| +8% | +$3.14M | 0.07% | 192 |
|
|
2025
Q3 | $31.9M | Sell |
65,746
-1,853
| -3% | -$863K | 0.07% | 236 |
|
|
2025
Q2 | $27.4M | Buy |
67,599
+6,614
| +11% | +$2.77M | 0.05% | 251 |
|
|
2025
Q1 | $30.3M | Buy |
60,985
+2,765
| +5% | +$1.5M | 0.07% | 216 |
|
|
2024
Q4 | $30.3M | Buy |
58,220
+1,696
| +3% | +$932K | 0.07% | 223 |
|
|
2024
Q3 | $35M | Sell |
56,524
-3,083
| -5% | -$1.82M | 0.09% | 188 |
|
|
2024
Q2 | $33M | Buy |
59,607
+6,783
| +13% | +$3.89M | 0.09% | 186 |
|
|
2024
Q1 | $30.7M | Sell |
52,824
-1,216
| -2% | -$682K | 0.08% | 212 |
|
|
2023
Q4 | $28.7M | Sell |
54,040
-5,691
| -10% | -$2.75M | 0.09% | 213 |
|
|
2023
Q3 | $30.2M | Sell |
59,731
-3,322
| -5% | -$1.77M | 0.09% | 210 |
|
|
2023
Q2 | $32.9M | Buy |
63,053
+273
| +0.4% | +$147K | 0.1% | 188 |
|
|
2023
Q1 | $36.2M | Buy |
62,780
+7,697
| +14% | +$4.34M | 0.11% | 173 |
|
|
2022
Q4 | $30.3M | Sell |
55,083
-235
| -0.4% | -$125K | 0.11% | 192 |
|
|
2022
Q3 | $28.1M | Sell |
55,318
-6,069
| -10% | -$3.4M | 0.11% | 166 |
|
|
2022
Q2 | $33.4M | Sell |
61,387
-24,027
| -28% | -$13.2M | 0.11% | 162 |
|
|
2022
Q1 | $50.4M | Sell |
85,414
-3,486
| -4% | -$2M | 0.11% | 172 |
|
|
2021
Q4 | $59.3M | Buy |
88,900
+19,101
| +27% | +$11.9M | 0.12% | 166 |
|
|
2021
Q3 | $39.9M | Sell |
69,799
-1,605
| -2% | -$881K | 0.11% | 161 |
|
|
2021
Q2 | $36M | Buy |
71,404
+13,124
| +23% | +$6.19M | 0.11% | 173 |
|
|
2021
Q1 | $26.6M | Buy |
58,280
+2,434
| +4% | +$1.16M | 0.08% | 199 |
|
|
2020
Q4 | $26M | Buy |
55,846
+5,665
| +11% | +$2.66M | 0.1% | 188 |
|
|
2020
Q3 | $22.2M | Buy |
50,181
+1,569
| +3% | +$648K | 0.1% | 169 |
|
|
2020
Q2 | $17.6M | Buy |
48,612
+5,398
| +12% | +$1.81M | 0.09% | 176 |
|
|
2020
Q1 | $12.3M | Sell |
43,214
-28,762
| -40% | -$9.07M | 0.09% | 179 |
|
|
2019
Q4 | $23.4M | Buy |
71,976
+14,545
| +25% | +$4.41M | 0.11% | 151 |
|
|
2019
Q3 | $16.7M | Buy |
57,431
+3,481
| +6% | +$997K | 0.09% | 171 |
|
|
2019
Q2 | $15.8M | Sell |
53,950
-10,131
| -16% | -$2.79M | 0.09% | 173 |
|
|
2019
Q1 | $17.5M | Buy |
64,081
+2,898
| +5% | +$721K | 0.11% | 165 |
|
|
2018
Q4 | $13.7M | Buy |
61,183
+4,859
| +9% | +$1.14M | 0.1% | 176 |
|
|
2018
Q3 | $13.7M | Sell |
56,324
-5,054
| -8% | -$1.16M | 0.09% | 170 |
|
|
2018
Q2 | $12.7M | Sell |
61,378
-4,380
| -7% | -$930K | 0.09% | 188 |
|
|
2018
Q1 | $13.6M | Buy |
65,758
+1,745
| +3% | +$366K | 0.09% | 188 |
|
|
2017
Q4 | $12.2M | Buy |
64,013
+18,722
| +41% | +$3.59M | 0.08% | 193 |
|
|
2017
Q3 | $8.57M | Buy |
45,291
+7,265
| +19% | +$1.32M | 0.08% | 234 |
|
|
2017
Q2 | $6.63M | Sell |
38,026
-1,138
| -3% | -$191K | 0.07% | 308 |
|
|
2017
Q1 | $6.02M | Buy |
39,164
+28
| +0.1% | +$4.28K | 0.06% | 313 |
|
|
2016
Q4 | $5.52M | Buy |
39,136
+7,585
| +24% | +$1.12M | 0.06% | 315 |
|
|
2016
Q3 | $5.02M | Sell |
31,551
-16,027
| -34% | -$2.47M | 0.07% | 221 |
|
|
2016
Q2 | $7.03M | Buy |
47,578
+581
| +1% | +$85.8K | 0.09% | 184 |
|
|
2016
Q1 | $6.65M | Sell |
46,997
-23,155
| -33% | -$3.1M | 0.09% | 195 |
|
|
2015
Q4 | $9.95M | Buy |
70,152
+3,671
| +6% | +$490K | 0.12% | 166 |
|
|
2015
Q3 | $8.13M | Buy |
66,481
+2,921
| +5% | +$381K | 0.11% | 184 |
|
|
2015
Q2 | $8.25M | Sell |
63,560
-14,734
| -19% | -$1.92M | 0.11% | 188 |
|
|
2015
Q1 | $10.5M | Sell |
78,294
-3,104
| -4% | -$400K | 0.12% | 177 |
|
|
2014
Q4 | $10.2M | Buy |
81,398
+13,384
| +20% | +$1.63M | 0.12% | 191 |
|
|
2014
Q3 | $8.28M | Sell |
68,014
-6,405
| -9% | -$779K | 0.11% | 180 |
|
|
2014
Q2 | $8.78M | Sell |
74,419
-5,522
| -7% | -$650K | 0.11% | 165 |
|
|
2014
Q1 | $9.61M | Buy |
79,941
+9,693
| +14% | +$1.15M | 0.12% | 147 |
|
|
2013
Q4 | $7.82M | Buy |
70,248
+33,439
| +91% | +$3.33M | 0.12% | 163 |
|
|
2013
Q3 | $3.39M | Sell |
36,809
-21,793
| -37% | -$1.97M | 0.08% | 205 |
|
|
2013
Q2 | $4.96M | Buy |
+58,602
| New | +$4.88M | 0.1% | 185 |
|
Other funds holding TMO
VCM
ProShare Advisors's TMO Position: Q1 2026 in Review
ProShare Advisors reduced its Thermo Fisher Scientific (TMO) stake by 19% in Q1 2026, selling an estimated $7.36M and leaving 57,741 shares worth $28.4M. The position accounts for 0.04% of the portfolio, ranked #207.
ProShare Advisors first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $59.3M in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- ProShare Advisors held 57,741 shares of Thermo Fisher Scientific worth $28.4M as of Q1 2026.
- ProShare Advisors sold 13,559 Thermo Fisher Scientific shares in Q1 2026, an estimated $7.36M.
- Thermo Fisher Scientific made up 0.04% of ProShare Advisors's portfolio in Q1 2026, its #207 holding.
- ProShare Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- ProShare Advisors's Thermo Fisher Scientific position peaked at $59.3M in Q4 2021.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.